fda sued over tirzepatide Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute FDA says the tirzepatide weight-loss

Most of these side effects are your bodys way of adjusting to slower digestion and reduced appetite core effects of how GLP-1s work

& Livingston, G

Copies of some of the documents referred to herein have been filed as exhibits to this Annual Report

This often happens because significant weight lossespecially when achieved quickly through GLP-1 medicationscan lead to the loss of lean muscle mass alongside fat

Current research and clinical experience generally indicate no specific harmful interactions (contraindications) between GLP-1 medications and common laxatives

Results were published in the New England Journal of Medicine in May 2025